ArrowMark Colorado Holdings LLC - TCR2 THERAPEUTICS INC ownership

TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 93 filers reported holding TCR2 THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ArrowMark Colorado Holdings LLC ownership history of TCR2 THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$467,000
-38.0%
259,6720.0%0.01%
-33.3%
Q2 2022$753,000
+5.0%
259,6720.0%0.01%
+50.0%
Q1 2022$717,000
-64.1%
259,672
-39.3%
0.01%
-62.5%
Q4 2021$1,995,000
-80.7%
428,088
-64.7%
0.02%
-80.2%
Q3 2021$10,327,000
-38.7%
1,213,498
+18.1%
0.08%
-36.2%
Q2 2021$16,855,000
-20.8%
1,027,128
+6.6%
0.13%
-20.1%
Q1 2021$21,276,000
-41.1%
963,606
-17.4%
0.16%
-43.2%
Q4 2020$36,102,000
+45.4%
1,167,220
-4.5%
0.28%
+18.1%
Q3 2020$24,825,000
+19.2%
1,221,699
-9.9%
0.24%
+10.2%
Q2 2020$20,828,000
+97.5%
1,356,010
-0.5%
0.22%
+55.8%
Q1 2020$10,547,000
-41.8%
1,362,653
+7.3%
0.14%
-14.3%
Q4 2019$18,132,000
+7.1%
1,269,766
+12.7%
0.16%
-4.7%
Q3 2019$16,928,000
+143.7%
1,126,307
+132.1%
0.17%
+152.2%
Q2 2019$6,945,000
-15.3%
485,332
+3.1%
0.07%
-13.0%
Q1 2019$8,204,000470,6980.08%
Other shareholders
TCR2 THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
MPM BioImpact LLC 6,741,964$208,528,00018.01%
MPM ASSET MANAGEMENT LLC 4,050,865$125,293,00017.73%
Consonance Capital Management LP 584,885$71,268,0006.66%
SILVERARC CAPITAL MANAGEMENT, LLC 136,000$4,206,0002.44%
Redmile Group, LLC 2,832,888$87,621,0001.06%
Altium Capital Management LP 73,991$2,289,0000.86%
PFM Health Sciences, LP 775,794$23,995,0000.84%
Soleus Capital Management, L.P. 199,867$6,182,0000.82%
MOODY ALDRICH PARTNERS LLC 123,639$3,824,0000.62%
Sofinnova Investments, Inc. 333,707$10,322,0000.61%
View complete list of TCR2 THERAPEUTICS INC shareholders